ETF Series Solutions Trust Loncar Cancer Immunotherapy ETF

$0.00 (0.00%) As of 11:01 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNCR and other ETFs, options, and stocks.

About CNCR

CNCR tracks an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs.

What's in this fund

Sectors

As of May 19, 2022
Healthcare100.00%

Top 10 Holdings (53.88% of total assets)

As of May 19, 2022
Name
Symbol
% Assets
Bristol-Myers Squibb
BMY
6.50%
Merck
MRK
6.45%
AstraZeneca
AZN
6.01%
argenx SE
ARGX
5.73%
Regeneron
REGN
5.52%
Legend Biotech
LEGN
5.23%
Immunocore
IMCR
4.98%
Gilead Sciences
GILD
4.67%
Iovance Biotherapeutics
IOVA
4.46%
Genmab
GMAB
4.33%

CNCR Key Statistics

AUM
21.13M
Price-Earnings ratio
-15.93
30-Day yield
-0.31
Average volume
6.15K
High today
$14.52
Low today
$14.49
Open price
$14.49
Volume
1.64K
52 Week high
$32.99
52 Week low
$13.08
Expense ratio
0.79

Average Annual Return

1Y3Y5Y10YSince
Oct 13, 2015
% Price Return-45.94%-6.34%-6.09%
—
-5.66%
% NAV Return-45.72%-6.37%-6.06%
—
-5.60%
As of April 30, 2022
All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. Current performance may be lower or higher than the performance data quoted. Full disclosure